Global Burden and Projections of Stroke Related to High Fasting Plasma Glucose in Young Adults: A Comparative Analysis From 1990 to 2050 Authors: Jiashuo Yang, Yan Yu, Jinlin Fan, Naibo Zhang, Honghe Li, Jian Zheng Published: 2026 ABSTRACT BackgroundTo characterize global trends in stroke and its subtypes attributable to high fasting plasma glucose (FPG) among young adults over the period 1990 to 2023 and to project these trends to 2050.MethodsUsing GBD (Global Burden of Disease) 2023 estimates, we quantified deaths, disability‐adjusted life years (DALYs), and age‐standardized rates of stroke, ischemic stroke (IS), and intracerebral hemorrhage (ICH) attributable to high FPG in adults aged 20 to 44 years, stratified by sex, age group, and sociodemographic index. A Bayesian age–period–cohort model was used to project trends to 2050.ResultsFrom 1990 to 2023, global stroke DALYs and deaths attributable to high FPG in young adults increased by 21.9% and 13.5%, while age‐standardized DALYs and death rates declined. IS‐attributable DALYs and deaths rose by 49% and 31%, versus 7.1% and 6.5% for ICH, with steeper declines in age‐standardized ICH rates, indicating a shift from ICH to IS. High and high‐middle–sociodemographic index regions showed marked declines in age‐standardized rates, whereas middle‐to‐low–sociodemographic index regions had stable or rising rates and the largest proportional increases in death. By 2050, DALYs from high FPG‐related stroke are projected to increase by 66.6% globally, with larger rises for IS than ICH (111.4% versus 40%).ConclusionsAmong young adults, the absolute burden of high FPG‐attributable stroke is growing, shifting toward IS and increasingly concentrated in women, adults aged 40 to 44 years, and lower–sociodemographic index regions, highlighting the need for earlier, targeted IS prevention in hyperglycemic young adults. Nonstandard Abbreviations and AcronymsBAPCBayesian age–period–cohortDALYdisability‐adjusted life yearFPGfasting plasma glucoseGBDGlobal Burden of DiseaseICHintracerebral hemorrhageISischemic strokeSDIsociodemographic index Clinical PerspectiveWhat Is New? Using GBD (Global Burden of Disease) 1990 to 2023 data and a Bayesian age–period–cohort model, this study quantified global, regional, sex‐ and age‐specific trends and projections to 2050 for stroke and its subtypes attributable to high fasting plasma glucose among adults aged 20 to 44 years.This study demonstrated a shift in the young adult stroke burden attributable to high fasting plasma glucose from intracerebral hemorrhage toward ischemic stroke, with absolute disability‐adjusted life years and deaths rising fastest in young women, adults aged 40 to 44 years, and low and low‐middle–sociodemographic index regions despite declining or stable age‐standardized rates. What Are the Clinical Implications? Clinicians should prioritize early detection and aggressive management of hyperglycemia in adults aged 20 to 44 years, particularly men and women in low‐resource settings; integrate glucose control with hypertension and stroke prevention; and tailor sex‐ and age‐specific strategies, focusing on intensive intervention before age 30 years and in those aged 40 to 44 years. Nonstandard Abbreviations and Acronyms Bayesian age–period–cohort disability‐adjusted life year fasting plasma glucose Global Burden of Disease intracerebral hemorrhage ischemic stroke sociodemographic index Clinical Perspective What Is New? Using GBD (Global Burden of Disease) 1990 to 2023 data and a Bayesian age–period–cohort model, this study quantified global, regional, sex‐ and age‐specific trends and projections to 2050 for stroke and its subtypes attributable to high fasting plasma glucose among adults aged 20 to 44 years.This study demonstrated a shift in the young adult stroke burden attributable to high fasting plasma glucose from intracerebral hemorrhage toward ischemic stroke, with absolute disability‐adjusted life years and deaths rising fastest in young women, adults aged 40 to 44 years, and low and low‐middle–sociodemographic index regions despite declining or stable age‐standardized rates. Using GBD (Global Burden of Disease) 1990 to 2023 data and a Bayesian age–period–cohort model, this study quantified global, regional, sex‐ and age‐specific trends and projections to 2050 for stroke and its subtypes attributable to high fasting plasma glucose among adults aged 20 to 44 years. Using GBD (Global Burden of Disease) 1990 to 2023 data and a Bayesian age–period–cohort model, this study quantified global, regional, sex‐ and age‐specific trends and projections to 2050 for stroke and its subtypes attributable to high fasting plasma glucose among adults aged 20 to 44 years. This study demonstrated a shift in the young adult stroke burden attributable to high fasting plasma glucose from intracerebral hemorrhage toward ischemic stroke, with absolute disability‐adjusted life years and deaths rising fastest in young women, adults aged 40 to 44 years, and low and low‐middle–sociodemographic index regions despite declining or stable age‐standardized rates. This study demonstrated a shift in the young adult stroke burden attributable to high fasting plasma glucose from intracerebral hemorrhage toward ischemic stroke, with absolute disability‐adjusted life years and deaths rising fastest in young women, adults aged 40 to 44 years, and low and low‐middle–sociodemographic index regions despite declining or stable age‐standardized rates. What Are the Clinical Implications? Clinicians should prioritize early detection and aggressive management of hyperglycemia in adults aged 20 to 44 years, particularly men and women in low‐resource settings; integrate glucose control with hypertension and stroke prevention; and tailor sex‐ and age‐specific strategies, focusing on intensive intervention before age 30 years and in those aged 40 to 44 years. Clinicians should prioritize early detection and aggressive management of hyperglycemia in adults aged 20 to 44 years, particularly men and women in low‐resource settings; integrate glucose control with hypertension and stroke prevention; and tailor sex‐ and age‐specific strategies, focusing on intensive intervention before age 30 years and in those aged 40 to 44 years. Clinicians should prioritize early detection and aggressive management of hyperglycemia in adults aged 20 to 44 years, particularly men and women in low‐resource settings; integrate glucose control with hypertension and stroke prevention; and tailor sex‐ and age‐specific strategies, focusing on intensive intervention before age 30 years and in those aged 40 to 44 years. Stroke is the second‐leading cause of death worldwide, as well as a major cause of severe disability. 1 In recent years, the incidence of stroke has decreased due to advancements in prevention and management strategies. However, the incidence of stroke among younger individuals relative to older adults has steadily risen over time. 2 , 3 This trend is likely driven by metabolic factors (eg, diabetes, obesity, and particularly hypertension) and unhealthy behaviors (smoking and physical inactivity). 4 , 5 The increasing stroke incidence among younger populations has placed substantial burdens on families and health care systems, as these patients often require long‐term medical resource allocation and experience significant productivity losses. 6 The World Health Organization Global Noncommunicable Disease Action Plan emphasizes that preventing early‐onset cardiovascular events is essential to reduce premature death and safeguard workforce productivity. 7 , 8 Therefore, investigating modifiable metabolic determinants affecting young adults has become a strategic priority in stroke prevention efforts. High fasting plasma glucose (FPG), a key marker of insulin resistance and abnormal glucose metabolism, is commonly regarded as an indicator of prediabetes. Evidence links elevated FPG to increased risks of cardiovascular disease, chronic kidney disease, and microvascular complications. 9 , 10 , 11 Mechanisms include accelerated atherosclerosis, increased blood viscosity, vascular endothelial dysfunction, and heightened inflammation. 12 Hyperglycemia exacerbates insulin resistance, triggers chronic inflammation and oxidative stress, impairs vascular endothelial function, and promotes atherogenesis. 13 Furthermore, high FPG may contribute to cognitive decline, particularly among individuals with coexisting metabolic disorders. 14 Clinical guidelines such as the American Diabetes Association Standards of Care and the American Heart Association Stroke Prevention Guidelines now recognize impaired FPG as a critical early‐stage intervention target. 15 , 16 High FPG is an independent risk factor for stroke, significantly increasing the risk regardless of whether diabetes diagnostic criteria are met or not. 9 , 17 Even mild hyperglycemia substantially elevates the risk of adverse outcomes, such as disability and death, following a stroke. 18 Thus, identifying and managing elevated FPG in younger adults may provide a window of opportunity to prevent long‐term vascular injury and reduce stroke incidence. Recognizing high FPG as an early warning indicator for stroke underscores the need for targeted interventions to reduce its incidence and improve long‐term outcomes. 17 , 19 However, current prevention frameworks largely focus on middle‐aged and older populations, resulting in gaps in early identification and management among younger individuals. By quantifying temporal trends and forecasting future stroke burdens attributable to high FPG, this study provides evidence for optimizing early metabolic screening, resource allocation, and stratified intervention strategies. Ultimately, the results may support the incorporation of young adults into national and regional stroke prevention programs, aligning with precision public health objectives. METHODS The data that support the findings of this study are available from the Global Health Data Exchange query tool (http://ghdx.healthdata.org/gbd‐results‐tool). The analytic methods and code used in this study are available from the corresponding author upon reasonable request. Overview and Data Sources Disability‐adjusted life‐years (DALYs) and death data for young adult stroke and subtypes attributable to high FPG from 1990 to 2023 were obtained from the Global Health Data Exchange tool (http://ghdx.healthdata.org/gbd‐results‐tool). The analytic methods and code used in this study are available from the corresponding author upon reasonable request. As this study was based on publicly available, aggregated, and deidentified data from the GBD (Global Burden of Disease) database, it was exempt from institutional review board approval and the requirement for informed consent. The platform, established by the Institute for Health Metrics and Evaluation, serves as a public repository that includes burden data derived from the GBD study. The methodologies of GBD study have been comprehensively detailed in prior literature. 20 Briefly, GBD study aims to improve health systems and address regional and temporal disparities by quantifying health losses across locations and time periods. The GBD 2023 study estimated epidemiological data for 375 diseases and 88 attributable risk factors across 204 countries and territories. 20 This study adhered strictly to the Strengthening the Reporting of Observational Studies in Epidemiology, as detailed in the supplement file (pages 47–48). Definitions In GBD studies, high FPG is defined as FPG levels exceeding the theoretical minimum risk exposure level. The theoretical minimum risk exposure level was calculated as the person‐year–weighted average of FPG levels associated with the lowest mortality risk in pooled analyses of prospective cohort studies and was estimated to range from 4.9 to 5.3 mmol/L. 21 This study focuses on young adult stroke and its subtypes, ischemic stroke (IS) and intracerebral hemorrhage (ICH), attributable to high FPG. The GBD study defines stroke on the basis of World Health Organization criteria as the sudden onset of clinical symptoms of focal brain dysfunction lasting >24 hours or resulting in death, with no other nonvascular cause identified. IS is defined as the obstruction of blood flow to brain tissue due to atherosclerotic or thromboembolic events, leading to infarction and excluding transient ischemic attacks. ICH refers to localized blood accumulation in the brain resulting from nontraumatic causes. Diagnoses of both IS and ICH were confirmed using validated International Classification of Diseases, Tenth Revision (ICD‐10) codes. Stroke burden estimation in the GBD study considered only the initial stroke event during a patient's lifetime. The health burden of young adult stroke and its subtypes attributable to high FPG was assessed using DALYs and death data. DALYs represent the sum of years of healthy life lost due to premature death and disability caused by disease. These measures are independently meaningful but interrelated; for instance, a higher death rate may correspond to higher DALYs. The GBD 2023 study stratifies 204 countries and regions into 5 categories based on the sociodemographic index (SDI): high, high‐middle, middle, low‐middle, and low. The SDI is an index that reflects the socioeconomic status of countries and regions and is influenced by factors such as educational attainment, per capita income, and fertility rates. This categorization helps analyze the relationship between economic development and variations in disease burden. Subgroups The burden of young adult stroke and its subtypes attributable to high FPG was assessed across sexes, age groups, and SDI regions. At present, there is a lack of a standard definition of this age group of young adults. The lower limit of the age range used by most studies was 15 or 19 years and the upper limit was 45 or 50 years. 22 , 23 , 24 Given that most young adult studies include the 20 to 44 years age period, the early adult–aged stage of this study was defined as ages 20 to 44 years. However, data on stroke and subtypes attributable to high FPG in individuals aged 20 to 24 years were unavailable in the GBD database; therefore, the age groups analyzed in this study were defined as 20 to 44, 25 to 29, 30 to 34, 35 to 39, and 40 to 44 years. Additionally, the study evaluated the burden of stroke and its subtypes attributable to high FPG across sexes and age groups within each SDI region. Statistical Analysis This study used the direct method to standardize all subgroups irrespective of age, according to the global standard age structure of GBD 2019. Age standardization adjusts demographic data to a common age composition, eliminating the influence of age as an irrelevant variable and thereby enhancing comparability between statistical indicators across different groups. Joinpoint regression is a widely used method in epidemiologic research for assessing temporal trends in disease incidence. The temporal trends were analyzed using the Joinpoint Regression Program version 5.2.0.0 (National Cancer Institute, Bethesda, MD). Based on robust methodological guidelines for a 33‐year continuous observational data set (n=33), the maximum number of joinpoints was set to 5. The specific temporal locations of these inflection points were identified using a continuous Grid Search algorithm that minimized the sum of squared errors. Subsequently, the optimal number of joinpoints was determined using a sequential step‐down Monte Carlo permutation test (running 4499 permutations), which effectively controls the type I error rate and averts model overfitting by comprehensively evaluating the pseudo‐likelihood ratio test statistics of permuted residuals. The joinpoint model was used to assess the temporal trend from 1990 to 2023 using the average annual percentage change and to calculate the 95% CI of the average annual percentage change. Average annual percentage change represents the annual average change rate of comprehensive evaluation variables within a specified interval. In this study, it was derived from the weighted average of slope coefficients from the joinpoint model between 1990 and 2023. If both the average annual percentage change value and its 95% CI are positive, the disease burden is considered to be gradually increasing. Furthermore, we used the Bayesian age–period–cohort (BAPC) model to predict the burden data for each group for 2024 to 2050 based on the global population projections of GBD 2016. Hyperparameters and model fit measures of the BAPC model are detailed in Tables S1 and S2. All data preprocessing and age‐standardization calculations were performed in R version 4.3.3 (R Foundation for Statistical Computing, Vienna, Austria). Joinpoint regression analyses were conducted using joinpoint software version 5.2.0.0 (National Cancer Institute). Figures were generated using Prism version 9.5.0 (GraphPad Software, La Jolla, CA) and Photoshop version 26.0.0 (Adobe, San Jose, CA). Results Global Burden of Stroke and Subtypes Attributable to High FPG Globally, DALYs of stroke for young adults attributable to high FPG increased by ≈21.9%, while death cases of stroke rose by ≈13.5% between 1990 and 2023 (Table1). The age‐standardized DALY and death rate of stroke remained declined. Table 1Burden of Stroke Attributable to High FPG Among Young Adults in 1990 and 2023CharacteristicDALYs (95% UI, 000s)Age‐standardized DALY rates (95% UI, per 100 000 people)Death cases (95% UI, 000s)Age‐standardized death rates (95%UI, per 100 000 people)1990202319902023AAPC (95%CI) P value1990202319902023AAPC (95%CI) P valueGlobal375.82 (187.75 to 734.71)458.21 (259.11 to 778.88)26.97 (26.88 to 27.06)19.63 (19.57 to 19.68)−0.98 (−1.17 to −0.789)<0.0016.16 (3.04 to 12.09)6.99 (3.99 to 12.06)0.45 (0.43 to 0.46)0.3 (0.29 to 0.31)−1.218 (−1.444 to −0.992)<0.001RegionHigh SDI149.76 (79.24 to 279.65)104.96 (63.05 to 172.67)24.18 (24.06 to 24.31)13.42 (13.34 to 13.5)−1.72 (−1.89 to −1.551)<0.0012.4 (1.2 to 4.5)1.36 (0.79 to 2.27)0.39 (0.37 to 0.4)0.17 (0.16 to 0.18)−2.372 (−2.641 to −2.102)<0.001High‐middle SDI111.72 (54.8 to 226.19)94.23 (54.63 to 158.75)37.14 (36.92 to 37.36)18.62 (18.5 to 18.74)−2.119 (−2.222 to −2.016)<0.0011.87 (0.89 to 3.91)1.4 (0.79 to 2.43)0.63 (0.6 to 0.66)0.28 (0.26 to 0.29)−2.49 (−2.614 to −2.366)<0.001Middle SDI40.28 (21.25 to 77.97)75.77 (44.41 to 129.99)28.88 (28.59 to 29.16)25.97 (25.79 to 26.16)−0.313 (−0.423 to −0.203)0.0010.66 (0.35 to 1.26)1.2 (0.67 to 2.09)0.48 (0.45 to 0.52)0−0.473 (−0.597 to −0.349)0.011Low‐middle SDI39.29 (18.47 to 81.42)92.36 (48.26 to 169.56)23.74 (23.51 to 23.98)27.34 (27.16 to 27.52)0.408 (0.161 to 0.656)0.0720.65 (0.3 to 1.35)1.52 (0.77 to 2.82)0.4 (0.37 to 0.43)0.45 (0.43 to 0.47)0.341 (0.077 to 0.605)0.421Low SDI34.49 (16.29 to 70.35)90.54 (47.9 to 168.23)20.73 (20.51 to 20.95)21.82 (21.68 to 21.96)0.137 (−0.012 to 0.288)<0.0010.58 (0.27 to 1.19)1.5 (0.77 to 2.79)0.37 (0.35 to 0.38)0.073 (−0.105 to 0.252)<0.001SexFemale152 (75.9 to 305.36)196.55 (108.63 to 368.26)22.2 (22.09 to 22.31)17.07 (16.99 to 17.14)−0.786 (−0.906 to −0.666)<0.0012.42 (1.14 to 4.93)2.89 (1.52 to 5.65)0.36 (0.34 to 0.37)0.25 (0.24 to 0.26)−1.049 (−1.253 to −0.844)<0.001Male223.83 (106.6 to 429.95)261.66 (148.75 to 438.05)31.58 (31.45 to 31.71)22.12 (22.04 to 22.21)−1.054 (−1.253 to −0.854)<0.0013.74 (1.66 to 7.21)4.1 (2.27 to 7.12)0.53 (0.52 to 0.55)0.35 (0.34 to 0.36)−1.344 (−1.452 to −1.237)<0.001Age group20 to 44 y375.82 (187.75 to 734.71)458.21 (259.11 to 778.88)25.58 (12.78 to 50)20.07 (11.35 to 34.12)−0.71 (−0.84 to −0.57)<0.0016.16 (3.04 to 12.09)6.99 (3.99 to 12.06)0.42 (0.21 to 0.82)0.31 (0.17 to 0.53)−0.92 (−1.1 to −0.73)<0.00120 to 24 yNANANANANANANANANANANANA25 to 29 y36.09 (16.62 to 79.31)31.54 (15.4 to 60.2)8.14 (3.75 to 17.88)5.39 (2.63 to 10.28)−1.25 (−1.35 to −1.16)<0.0010.45 (0.19 to 0.97)0.34 (0.16 to 0.67)0.1 (0.04 to 0.22)0.06 (0.03 to 0.12)−1.62 (−1.75 to −1.48)<0.00130 to 34 y58.48 (26.9 to 124.28)67.44 (35.6 to 119.85)15.14 (6.97 to 32.18)11.3 (5.96 to 20.08)−0.85 (−0.98 to −0.72)<0.0010.82 (0.37 to 1.78)0.87 (0.45 to 1.55)0.21 (0.1 to 0.46)0.15 (0.08 to 0.26)−1.12 (−1.28 to −0.96)<0.00135 to 39 y104.47 (52.1 to 203.94)129.07 (72.35 to 218.63)29.61 (14.77 to 57.81)22.1 (12.39 to 37.43)−0.89 (−1.06 to −0.73)<0.0011.66 (0.79 to 3.32)1.88 (1.06 to 3.25)0.47 (0.22 to 0.94)0.32 (0.18 to 0.56)−1.2 (−1.48 to −0.92)<0.00140 to 44 y176.79 (92.13 to 327.19)230.16 (135.76 to 380.2)61.6 (32.1 to 114)44.54 (26.27 to 73.58)−0.96 (−1.26 to −0.66)<0.0013.23 (1.69 to 6.02)3.89 (2.31 to 6.59)1.13 (0.59 to 2.1)0.75 (0.45 to 1.28)−1.19 (−1.55 to −0.82)<0.001AAPC indicates average annual percent change; DALY, disability‐adjusted life‐year; FPG, fasting plasma glucose; SDI, sociodemographic index; and UI, uncertainty interval. Burden of Stroke Attributable to High FPG Among Young Adults in 1990 and 2023 AAPC indicates average annual percent change; DALY, disability‐adjusted life‐year; FPG, fasting plasma glucose; SDI, sociodemographic index; and UI, uncertainty interval. DALYs for IS in young adults attributable to high FPG increased by 49%, while death cases rose by 31% (Table S3). Both the age‐standardized DALY rate and age‐standardized death rate showed decline. Additionally, ICH in young adults attributable to high FPG experienced a 7.1% increase in DALYs and a 6.5% rise in death cases (Table S4). Both the age‐standardized DALY rate and age‐standardized death rate for ICH declined. ICH demonstrated a more pronounced decline than IS in both the age‐standardized DALY rate and the age‐standardized death rate (Tables S3 and S4). These findings suggest that over the past 3 decades, the primary stroke burden attributable to high FPG in the populated aged 20 to 44 years has gradually shifted from ICH to ischemic stroke IS. Global Burden of Stroke and Subtypes Attributable to High FPG by Sex DALYs for stroke attributable to high FPG in both young men and women increased consistently from 1990 to 2023, with a greater rise observed in women (Figure 1A; Table 1). A similar trend was observed in death cases attributable to high FPG, with increases of 9.6% in men and 19.4% in women (Figure 1A; Table 1). Notably, DALYs and death cases of stroke attributable to high FPG were persistently higher in men compared with women over the past 3 decades. Trends in DALYs and deaths by sex from 1990 to 2023, including age‐standardized rates and male‐to‐female ratios. A, DALYs and death cases by sex from 1990 to 2023. B, DALYs and death cases by sex in 1990 and 2023. C, Age‐standardized DALY rates and death rates by sex and male‐to‐female ratios of age‐standardized death rates from 1990 to 2023. D, Age‐standardized DALY rates and death rates by sex in 1990 and 2023. E, AAPCs of age‐standardized DALY rates and death rates by sex between 1990 and 2023. AAPC indicates average annual percentage change; DALY, disability‐adjusted life‐year; and ns, not significant. **P<0.01; ***P<0.001. DALYs in both young men and women exceeded 1990 levels by 2023 among stroke and subtypes attributable to high FPG (Figure 1B; Table 1; Tables S3 and S4). Young men exhibited far more DALYs attributable to ICH than women, whether in 1990 or 2023. A similar pattern was observed in death cases (Figure 1B). According to the stroke subtypes, the ICH due to high FPG exhibits a more pronounced male propensity than IS (Figure 1C). Notably, among young women, the DALYs for IS were substantially lower than for ICH in 1990 but had reached comparable levels by 2023, with only a slight disparity (Figure 1B; Tables S3 and S4). The age‐standardized death rate of IS attributable to high FPG showed a steady decline in both young men and women from 1990 to 2023 and indicated a faster rate of decline in men (Figure 1C and 1E; Table S3). The age‐standardized death rate of ICH decreased in both sexes, with a more pronounced decline observed in men. The age‐standardized DALY rate of IS declined significantly in young men but did not change significantly in women (Figure 1C and 1E; Table S3). For ICH, the age‐standardized DALY rate declined in both sexes, with a more substantial decrease in men (Figure 1C and 1E; Table S4). These shifts resulted in a male‐to‐female ratio >1 for the age‐standardized death of high FPG‐related stroke and all subtypes. It is noteworthy that after years of increase, this ratio reached a peak and subsequently exhibited a sustained yet gradual downward trend starting in 2010 (Figure 1C). The primary reason for the decrease in the age‐standardized DALY rate of stroke attributable to high FPG in young women by 2023 is the rapid decline in the age‐standardized DALY rate of ICH (Figure 1D and 1E; Table S4). In young men, the notable reduction in the age‐standardized stroke DALY rate was driven by parallel declines in the age‐standardized DALY rates for IS and ICH (Figure 1D and 1E; Table S3). Global Burden of Stroke and Subtypes Attributable to High FPG by Age Groups In all age groups, DALYs for young adults with stroke attributable to high FPG increased from 1990 to 2023, with the largest increase observed in the 40 to 44 years age group (Figure 2A; Table 1). However, the DALY rate declined in each age group over the past 3 decades (Figure 2B; Table 1). An increase in high FPG‐related stroke death cases was observed in all young adult age groups except for the population aged 25 to 29 years (Figure 2A; Table 1). The 40 to 44 years age group experienced the largest increase in death cases attributable to high FPG, with an increase of ≈20.4%. Notably, a more pronounced decline in the DALY rate of high‐FPG–attributable stroke was observed in the 25 to 29 and 40 to 44 years age groups (Figure 2B; Table 1). DALYs, deaths, and their trends by age groups from 1990 to 2023. A, DALYs, death cases, DALY rates, and death rates by age groups (5‐year intervals) from 1990 to 2023. B, AAPCs of DALY rates and death rates by age groups (5‐year intervals) between 1990 and 2023. C, Contribution of each subtype to total DALYs and total death cases by age groups (5‐year intervals) in 1990 and 2023. D, Contribution of each age group (5‐year intervals) to total DALYs and total death cases in subtypes in 1990 and 2023. E, DALY rates and death rates in subtypes by age groups (5‐year intervals) from 1990 to 2023. F, AAPCs of DALY rates and death rates in subtypes by age groups (5‐year intervals) between 1990 and 2023. AAPC indicates average annual percentage change; DALY, disability‐adjusted life‐year; and ns, not significant. *P<0.05; **P<0.01; ***P<0.001. Across all age subgroups, the highest proportion of IS among stroke‐related DALYs caused by high FPG was in the 25 to 29 years age group, accounting for 35.56% in 1990 and 45.71% in 2023 (Figure 2C). In contrast, across all age subgroups, the proportion of IS among stroke‐related death cases was lowest in the 25 to 29 years age group, representing 24.81% in 1990 and 31.29% in 2023 (Figure 2C). Although the burden of IS attributable to high FPG increased significantly from 1990 to 2023, ICH remains the predominant contributor to the burden caused by high FPG among individuals aged 20 to 44 years (Figure 2C). Aging is an independent risk factor for stroke, whether it is IS or ICH (Figure 2D). The DALY rate of IS caused by high FPG declined across all age groups from 1990 to 2023, with the most pronounced decline observed in the 25 to 29 years age group (Figure 2E and 2F; Table S3). The DALY rate of ICH decreased significantly across all age groups, with the largest decrease in the 25 to 29 years age group (Figure 2E and 2F; Table S4). Regarding death rates, the death rate for ICH and IS decreased significantly in all age groups, with the largest decline observed in the 25 to 29 years age group (Figure 2E and 2F; Table S4). Burden of Stroke and Subtypes Attributable to High FPG by SDI Region, Sex, and Age Groups Between 1990 and 2023, the DALYs attributable to high FPG‐related stroke showed an upward trend across all SDI regions, with the notable exception of the high and high‐middle–SDI region. It is important to note that, despite its declining trend, the DALY burden in the high‐SDI region remained consistently higher than in all other regions throughout this period (Figure 3A). The largest increase occurred in the low SDI region, reaching 62.5% (Table 1). Although the low‐SDI region exhibited the most pronounced increase (158.6%) in stroke‐related death cases between 1990 and 2023, the high‐SDI region reported the highest number for most of this period (Figure 3A; Table 1). By 2023, however, the low‐SDI region had overtaken the high‐SDI region, with its death count second only to that of the low‐middle–SDI region. DALYs, deaths, and age‐standardized rates by SDI regions from 1990 to 2023. A, DALYs and death cases by SDI regions from 1990 to 2023. B, Age‐standardized DALY rates and death rates in SDI regions by subtypes from 1990 to 2023. C, Age‐standardized DALY rates and death rates in subtypes by SDI regions from 1990 to 2023. DALY indicates disability‐adjusted life‐year; and SDI, sociodemographic index. Between 1990 and 2023, the age‐standardized stroke DALY rates attributable to high FPG showed a marked decline in the high‐ and high‐middle–SDI regions, while remaining relatively stable in the other 3 SDI regions over the same period (Figure 3B). Specifically, the high‐middle–SDI region had the highest age‐standardized DALY rate from 1990 to 2003, which shifted to the middle SDI region from 2004 to 2006. By 2007, the low‐middle–SDI region had the highest age‐standardized DALY rate. Among all SDI regions, from 1990 to 2023, the high‐ and high‐middle–SDI regions saw a significant decline in the age‐standardized DALY rate for IS due to high FPG. In contrast, the middle‐ and low‐middle–SDI regions experienced a considerable increase over the same period (Figure 3B; Table S3). While notable declines in age‐standardized DALY rates for ICH were observed in both the high‐ and high‐middle–SDI regions, the reduction was most pronounced in the high‐middle–SDI region (Table S4). Trends in age‐standardized death rates across SDI regions mirrored those of age‐standardized DALY rates, with the low‐middle–SDI region having the highest age‐standardized death rate for stroke attributable to high FPG after 2006 (Figure 3B). Notably, the age‐standardized DALY rate for IS surpassed that of ICH in the high‐SDI region as early as 2017, but in other regions, it remained lower. In terms of age‐standardized death rates, IS was consistently associated with lower rates than ICH across all SDI regions from 1990 to 2023 (Figure 3C). Across all SDI regions, the age‐standardized DALY rates for stroke and its subtypes were almost universally higher in men than in women, with this disparity being particularly pronounced in the high‐ and high‐middle–SDI regions (Figure 4A; Table S5). However, in recent years, the age‐standardized DALY rates for ICH attributable to high FPG among young women have surpassed those of their male counterparts in low‐ and lower‐middle–SDI regions. Notably, the age‐standardized DALY rate ratio of stroke between men and women gradually decreased in all SDI regions. Similar trends were observed for age‐standardized death rate ratios (Figure 4A), with IS‐related age‐standardized death rates in young women surpassing those of men in low‐ and low‐middle–SDI regions over the past decade. Male‐to‐female ratios and AAPCs of DALY and death rates by SDI regions from 1990 to 2023. A, Male‐to‐female ratios of age‐standardized DALY rates and death rates by men to women in subtypes by SDI regions from 1990 to 2023. B, AAPCs of DALY rates and death rates for stroke and subtypes by age groups and SDI regions between 1990 and 2023. DALY indicates disability‐adjusted life‐year; ns, not significant; and SDI, sociodemographic index. *P<0.05; **P<0.01; ***P<0.001. From 1990 to 2023, a convergent decline in high FPG‐attributable IS DALY rates was observed across all age groups in the high‐ and high‐middle–SDI regions, in contrast to an upward trajectory in all other regions (Figure 4B). The age groups with the most rapid increases varied by region: 25 to 29 years in middle‐SDI regions and 35 to 39 years in low‐ and low‐middle–SDI regions (Table S6). For ICH, a universal downward trend in DALY rates was observed across almost all age groups in every region, with notable exceptions confined to the 40 to 44 years age group in the low‐middle–SDI region and the 35 to 39 years age group in the low‐SDI region. Death rates for IS attributable to high FPG increased in all age groups in middle‐, low‐middle–, and low‐SDI regions from 1990 to 2023 (Figure 4B). Notably, although the fastest increase in the DALY rate of IS in low‐ to middle‐SDI regions occurred in the 30 to 34 years age group, the fastest increase in the death rate occurred in the 40 to 44 years age group (Table S6). Predicted Burden of Stroke and Subtypes Attributable to High FPG by 2050 According to the BAPC model's forecast, global DALYs for stroke attributable to high FPG among young adults aged 20 to 44 years are projected to increase by 16.7% between 2023 and 2030 and by 66.6% by 2050 (Table S7). Among these, DALYs attributable to IS are expected to increase more significantly than those from ICH (2023–2030: 21.9% versus 13%; 2023–2050: 111.4% versus 40%). The global number of stroke‐related death cases among young adults aged 20 to 44 years is also projected to rise. Notably, death cases from IS are expected to increase by 10.8% from 2023 to 2030 and by 39.9% by 2050. Globally, DALYs and death cases for all stroke subtypes attributable to high FPG are expected to rise among young men and women aged 20 to 44 years (Table S7). Young women are projected to have greater increases in DALYs for stroke compared with men (2023–2030: 34.3% versus 5.5%; 2023–2050: 198.6% versus 10.1%). Death cases for stroke among young women are expected to increase more than in men (2023–2030: 27.2% versus −2%; 2023–2050: 40.8% versus −34.3%). Across age groups, death cases for stroke are expected to temporarily decline before increasing in individuals aged 30 to 34 years and 35 to 39 years, while consistently increasing in those aged 25 to 29 years and 40 to 44 years, particularly in the 40 to 44 years age group. For example, in individuals aged 40 to 44 years, DALYs and death cases from IS are projected to increase by 17.8% and 17.7%, respectively, from 2023 to 2030. The BAPC model predicts that the DALY rate for stroke attributable to high FPG in young adults aged 20 to 44 years will consistently increase from 2023 to 2050 (Figure 5A). Across all age groups, the DALY rates attributable to high FPG are projected to rise continuously and to exceed those of ICH by 2050, except for the 40 to 44 years age group. In contrast, IS death is not forecast to surpass ICH death within the same time frame (Figure 5B). For young men, the age‐standardized DALY rate for ICH attributable to high FPG is projected to continue declining after 2023, falling below that of IS by 2046. In contrast, the rate for young women is forecast to rise and remain elevated above the IS level throughout the projection period (Figure 5C). Notably, while the age‐standardized DALY rate of IS in both young men is projected to remain stable after 2023, the age‐standardized death rate will continue to decline (Figure 5D). According to our predictions, the age‐standardized stroke rate decreased or remained stable in most SDI regions but may increase in middle‐ and low‐SDI regions (Figure S1A and S1B). The increase in the age‐standardized rate of stroke in the middle‐SDI region was due to the increase in ischemic stroke, whereas the low‐SDI region was due to the dual increase in ischemic stroke and cerebral hemorrhage. According to our projections, the ratio of age‐standardized rates by men to women will continue to decline in all SDI regions by 2050. As the SDI value decreases, women experience an earlier time to reach an age‐standardized stroke rate higher than that of men, whether measured by DALYs or deaths (Figure S2A and S2B). Predicted DALY and death rates by age groups from 1990 to 2050. A, Predicted DALY rates in subtypes by age groups from 1990 to 2050. B, Predicted death rates in subtypes by age groups from 1990 to 2050. C, Predicted age‐standardized DALY rates in subtypes by sex from 1990 to 2050. D, Predicted age‐standardized death rates in subtypes by sex from 1990 to 2050. DALY indicates disability‐adjusted life‐year. Discussion This study examines the increasing burden of stroke and its subtypes attributable to high FPG in young adults, expanding current understanding of this issue by analyzing trends from 1990 to 2023 and projecting burden to 2050. These findings are consistent with the World Health Organization Global Action Plan for the Prevention and Control of Noncommunicable Diseases, which describes a younger shift in metabolic risk exposure. 7 , 8 This highlights the relevance of young adults as an important population in cardiovascular risk surveillance. Hypertension remains the leading risk factor for ICH and a primary target for ICH prevention. Our work is intended to complement, rather than replace, the established emphasis on hypertension control by quantifying the specific contribution and trends of high FPG–related stroke burden among young adults. Potential interactions between high FPG and blood pressure should therefore be interpreted cautiously. 25 Because high FPG and hypertension frequently co‐occur, some of the burden we attribute to high FPG arises in individuals with multiple concomitant risk factors and cannot be fully separated from the contribution of elevated blood pressure, especially for ICH. Our estimates should thus be interpreted as the incremental population‐level burden associated with high FPG, not as implying that high FPG is the dominant or exclusive driver of ICH. More broadly, the GBD framework quantifies population‐level burden attributable to high FPG based on comparative risk assessment, rather than establishing direct causal relationships at the individual level. From 1990 to 2023, DALYs and death cases from stroke attributable to high FPG among individuals aged 20 to 44 years rose substantially, whereas age‐standardized DALY and death rates declined. This “relative improvement but absolute worsening” pattern is consistent with global stroke and diabetes trends and reflects the combined effects of population growth, demographic change, and expanding exposure to metabolic risks in younger cohorts. 16 , 25 , 26 , 27 , 28 We suspect that, although individual risk profiles and case fatality have improved, these gains are being offset by the fact that hyperglycemia and related metabolic disorders are now affecting more people and occurring at younger ages across the population. Additionally, the major burden of stroke attributable to high FPG is shifting from ICH to IS. Similar transitions have been described in recent American Heart Association/American Stroke Association stroke surveillance reports, in parallel with increasing prevalence of metabolic risk factors. 16 , 26 In our analysis, DALYs and death cases from IS attributable to high FPG increased much faster than those from ICH, while ICH showed a more pronounced decline in age‐standardized DALY and death rates. Advances in acute stroke care and blood pressure detection and control may have contributed to declining ICH fatality and disability, 29 , 30 whereas the growing prevalence of metabolic disorders may have increased the proportional IS burden attributable to high FPG. 31 , 32 IS has already surpassed ICH as the main source of high FPG–related stroke burden in young adults in high‐SDI regions, while ICH remains dominant in most other regions. Young men experienced a greater attributable stroke burden than women. 33 , 34 This may reflect age‐specific differences in stroke risk profiles. 35 All‐age studies have reported stronger relative associations between diabetes and stroke in women 36 and poorer poststroke outcomes in women than in men. 37 , 38 Our results show a clear male predominance in young stroke and its subtypes attributable to high FPG across the study period, particularly for ICH, with consistently higher DALYs and death cases in men. Nevertheless, temporal and projection analyses indicate that the relative increase in high FPG–related stroke burden is steeper in young women than in men, suggesting that, if current trends persist, young women will contribute disproportionately to future growth in DALYs and deaths. This is consistent with evidence that the cardiovascular consequences of hyperglycemia and diabetes may be especially pronounced in women. 36 , 39 The steeper relative increase in high FPG–related stroke burden among young women, despite their lower absolute risk of recurrent events, 40 may reflect several underrecognized factors. These include inadequate management of vascular risk, sex‐specific hormonal exposures (eg, gestational diabetes, polycystic ovary syndrome, contraceptive use), and structural barriers to preventive care, particularly in low‐ and low‐middle–SDI settings. 39 , 41 These factors have been proposed in previous studies and may be particularly relevant in low‐ and low‐middle–SDI settings, although they cannot be directly tested in our GBD‐based analysis. These age‐ and sex‐specific patterns are important for prevention planning. They suggest that young men represent a traditionally underappreciated high‐risk group for high FPG–attributable stroke, while young women, especially in low‐resource settings, are emerging as a rapidly growing source of future burden. This dual focus aligns with American Diabetes Association and American Heart Association recommendations for sex‐sensitive cardiovascular prevention strategies. 15 , 16 Combined with our analysis and predictions, we observed a continuous downward trend in the male‐to‐female ratio of the overarching stroke burden among all SDI regions, a unique trajectory that is projected to persist in the coming decades. This shifting of stroke burden toward women may be attributed to structural and clinical inequities within global health care systems. Substantial evidence indicates that female patients with stroke frequently present with atypical neurological symptoms, which inherently leads to clinical misdiagnoses, prolonged door‐to‐needle times, and systematically lower use rates of acute reperfusion therapies. 42 , 43 Furthermore, postdischarge real‐world data suggest that women exhibit lower adherence to and attainment of secondary prevention targets, such as aggressive lipid‐lowering and sustained anticoagulant regimens, ultimately contributing to higher stroke recurrence rates and poorer functional survivorship. 44 Consequently, navigating the future epidemiological landscape of stroke necessitates a pivotal paradigm shift toward sex‐specific and sex‐sensitive prevention, early recognition, and management strategies. Given the steep relative declines in IS and ICH DALY and death rates among those aged 25 to 29 years, and the still relatively low absolute burden in the early 30s, these ages may represent a critical window for detecting elevated FPG and implementing intensive metabolic risk management. Such age‐tailored strategies align with World Health Organization recommendations for integrating chronic disease prevention within workplace and community health systems and targeting adults in early working life. 6 , 45 , 46 Marked regional differences in the distribution of burden underscore substantial heterogeneity in high‐FPG–attributable stroke across sociodemographic contexts. Low‐SDI regions are showing the largest proportional increases and, by 2023, surpassing high‐SDI regions in stroke deaths. Low‐middle–SDI regions now have the highest age‐standardized mortality rates attributable to high FPG. IS has recently overtaken ICH as the leading source of DALYs in high‐SDI regions, whereas ICH remains predominant elsewhere. These regional patterns are broadly consistent with prior work demonstrating relatively greater diabetes and IS burden in higher‐SDI settings and persistent predominance of ICH with limited stroke care capacity in many low‐ and middle‐SDI regions. 26 , 47 , 48 , 49 Similar geographic patterns for diabetes and ischemic stroke, compared with those for ICH, may reflect the closer alignment of metabolic risk profiles with ischemic cerebrovascular disease, 50 , 51 although GBD comparative risk assessment quantifies population‐level attributable burden rather than differences in individual‐level causal effects across regions. The rapid rise in high FPG‐related stroke death cases in low‐ and low‐middle–SDI regions highlights the urgency of strengthening metabolic risk assessment, hypertension control, and stroke care systems in resource‐constrained settings. 26 , 49 , 52 In low‐ and low‐middle–SDI regions, we observed a recent shift: ICH DALY rates attributable to high FPG in young women have surpassed those in men, and IS‐related age‐standardized death rates in young women have exceeded those in men over the past decade. These findings mirror rapid increases in cardiometabolic risk among women in many low‐resource settings, driven by urbanization, nutritional transition, and inequities in access to preventive and acute cardiovascular care. 41 , 52 , 53 Factors such as lifestyle, living environment, reproductive and hormonal exposures, and health system performance likely contribute to these patterns. 54 In high‐ and high‐middle–SDI regions, IS‐attributable DALY rates for high FPG declined across all young adult age groups between 1990 and 2023. By contrast, these DALY rates increased in middle‐, low‐middle–, and low‐SDI regions, particularly in early and mid‐young adulthood. These differences support differentiated prevention models: high‐SDI regions may prioritize corporate wellness programs, digital metabolic monitoring, and individualized risk management in early working life. Lower‐SDI regions require population‐level screening campaigns, stronger primary health care, and improved access to affordable antihypertensive and glucose‐lowering medications. 52 , 55 , 56 Projections from the BAPC model suggest that, if current trends continue, the absolute burden of stroke attributable to high FPG in young adults will continue to rise to 2030 and 2050, even as several age‐standardized rates decline or stabilize. The future burden is projected to shift increasingly toward IS, with ICH contributing a smaller share, particularly among young men. Young women are expected to experience larger proportional increases in DALYs and deaths from high FPG–attributable stroke than young men, although men will likely continue to bear a higher absolute burden in many settings. These projections are broadly consistent with previous forecasting studies of global and young‐onset ischemic stroke burden and cardiometabolic risk 57 , 58 and underscore young adulthood as a critical life stage for monitoring metabolic risk and planning stroke prevention strategies at scale. Greater attention to modifiable metabolic factors earlier in the life course, particularly high FPG, will be essential for bending the long‐term trajectory of stroke burden in future generations. 6 , 27 Notably, whereas age‐standardized DALY and death rates attributable to high FPG–related stroke declined between 1990 and 2023, our BAPC projections suggest a reversal of this trend for DALY rates in young adults, particularly for IS. This divergence likely reflects assumptions about future trajectories of high FPG exposure, demographic change, and potential saturation of improvements in acute stroke care. Given the considerable and unavoidable uncertainty surrounding long‐term projections, these forecasts should be viewed only as illustrative, scenario‐based estimates, rather than as precise or definitive predictions. This study has several limitations. First, the raw data are model‐based estimates derived from existing epidemiological information and should be interpreted alongside real‐world data. Second, estimates may be more uncertain in regions with limited surveillance, where model‐based borrowing of strength across locations and time may not capture local heterogeneity. 25 Third, we were unable to model the joint or interactive effects of high FPG and high blood pressure on stroke subtypes, and this constrains the interpretation of our results, particularly on ICH. Fourth, model choice and parameter assumptions, including those in the BAPC forecasting framework, may have influenced trend and projection estimates. Fifth, our analysis is based on the latest available GBD 2023 release; future work should update these trends as new data, diagnostic practices, and treatment patterns emerge. Finally, future trends may deviate from our projections due to unforeseen changes in clinical practice, public health policies, socioeconomic conditions, or therapeutic advances. The findings should therefore be validated and refined through real‐world epidemiological studies and high‐quality stroke registries in diverse regions and health system contexts. Conclusions Among adults aged 20 to 44 years, global stroke DALYs and deaths attributable to high FPG have risen substantially despite declining age‐standardized rates. ICH still accounts for most of this burden worldwide, but IS contributes an increasing share, particularly in high‐SDI regions and in projections to 2050, indicating a gradual shift in subtype patterns rather than a complete transition. Young men currently bear higher burdens than women, especially for ICH, yet relative increases and projected growth are steeper in young women. The burden is greatest at ages 40 to 44 years, while the late 20s and early 30s emerge as a key window for prevention. These estimates, based on the GBD comparative risk assessment, represent incremental population‐level burden from high FPG, which often co‐occurs with hypertension. They support integrating FPG detection and management into cardiometabolic stroke prevention for young adults, tailored by sex, age, and SDI level, with particular emphasis on lower‐SDI settings and young women. Sources of Funding This work is supported by the Education Department of Liaoning Provincial Basic Research Projects (JYTMS20230098) and the 30 Project Fund of Shengjing Hospital (M0269). Disclosures All authors declare no conflicts of interest. Supporting information Tables S1–S7 Figures S1 and S2 STROBE checklist